These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14691757)

  • 21. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease.
    Kandinov B; Giladi N; Korczyn AD
    Parkinsonism Relat Disord; 2007 May; 13(4):243-5. PubMed ID: 17275394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Smoking and Parkinson's disease].
    Cazzato G; Capus L; Monti F; Carraro N
    Riv Neurol; 1985; 55(2):79-87. PubMed ID: 4012192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking in Parkinson's disease: influence on disease progression.
    Alves G; Kurz M; Lie SA; Larsen JP
    Mov Disord; 2004 Sep; 19(9):1087-1092. PubMed ID: 15372603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
    Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal study of mortality predictors in Parkinson's disease in Nigerians.
    Okubadejo NU; Ojini FI; Danesi MA
    Afr J Med Med Sci; 2005 Dec; 34(4):365-9. PubMed ID: 16752667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality in Parkinson's disease and its association with dementia and depression.
    Hughes TA; Ross HF; Mindham RH; Spokes EG
    Acta Neurol Scand; 2004 Aug; 110(2):118-23. PubMed ID: 15242420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis.
    Costenbader KH; Kim DJ; Peerzada J; Lockman S; Nobles-Knight D; Petri M; Karlson EW
    Arthritis Rheum; 2004 Mar; 50(3):849-57. PubMed ID: 15022327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
    Nuti A; Ceravolo R; Dell'Agnello G; Gambaccini G; Bellini G; Kiferle L; Rossi C; Logi C; Bonuccelli U
    Parkinsonism Relat Disord; 2004 Dec; 10(8):481-5. PubMed ID: 15542008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do pacifiers reduce the risk of sudden infant death syndrome? A meta-analysis.
    Hauck FR; Omojokun OO; Siadaty MS
    Pediatrics; 2005 Nov; 116(5):e716-23. PubMed ID: 16216900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cigarette smoking and the risk of endometrial cancer: a meta-analysis.
    Zhou B; Yang L; Sun Q; Cong R; Gu H; Tang N; Zhu H; Wang B
    Am J Med; 2008 Jun; 121(6):501-508.e3. PubMed ID: 18501231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease.
    Fong CS; Cheng CW; Wu RM
    Acta Neurol Taiwan; 2005 Jun; 14(2):55-60. PubMed ID: 16008163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Parkinsonism Relat Disord; 2009 Feb; 15(2):153-5. PubMed ID: 18514013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Young-onset Parkinson's disease: hospital utilization and medical comorbidity in a nationwide survey.
    Louis ED; Henchcliffe C; Bateman BT; Schumacher C
    Neuroepidemiology; 2007; 29(1-2):39-43. PubMed ID: 17898522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.
    Atsma F; Bartelink ML; Grobbee DE; van der Schouw YT
    Menopause; 2006; 13(2):265-79. PubMed ID: 16645540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective cohort study of Parkinson's disease in Korean shipbuilders.
    Park J; Yoo CI; Sim CS; Kim JW; Yi Y; Shin YC; Kim DH; Kim Y
    Neurotoxicology; 2006 May; 27(3):445-9. PubMed ID: 16483661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Progress in the basic and clinical aspects of Parkinson's disease].
    Mizuno Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):741-50. PubMed ID: 15651281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is implicit sequence learning impaired in Parkinson's disease? A meta-analysis.
    Siegert RJ; Taylor KD; Weatherall M; Abernethy DA
    Neuropsychology; 2006 Jul; 20(4):490-5. PubMed ID: 16846267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cigarette smoking and adenomatous polyps: a meta-analysis.
    Botteri E; Iodice S; Raimondi S; Maisonneuve P; Lowenfels AB
    Gastroenterology; 2008 Feb; 134(2):388-95. PubMed ID: 18242207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
    Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Parkinson s disease risk factors].
    Allam MF; del Castillo AS; Navajas RF
    Rev Neurol; 2003 Apr 16-30; 36(8):749-55. PubMed ID: 12717655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.